Cell Reports (Nov 2019)

Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils for NET Formation

  • Esther Hoste,
  • Christian Maueröder,
  • Lisette van Hove,
  • Leen Catrysse,
  • Hanna-Kaisa Vikkula,
  • Mozes Sze,
  • Bastiaan Maes,
  • Dyah Karjosukarso,
  • Liesbet Martens,
  • Amanda Gonçalves,
  • Eef Parthoens,
  • Ria Roelandt,
  • Wim Declercq,
  • Ignacia Fuentes,
  • Francis Palisson,
  • Sergio Gonzalez,
  • Julio C. Salas-Alanis,
  • Louis Boon,
  • Peter Huebener,
  • Klaas Willem Mulder,
  • Kodi Ravichandran,
  • Yvan Saeys,
  • Robert Felix Schwabe,
  • Geert van Loo

Journal volume & issue
Vol. 29, no. 9
pp. 2689 – 2701.e4

Abstract

Read online

Summary: Regenerative responses predispose tissues to tumor formation by largely unknown mechanisms. High-mobility group box 1 (HMGB1) is a danger-associated molecular pattern contributing to inflammatory pathologies. We show that HMGB1 derived from keratinocytes, but not myeloid cells, delays cutaneous wound healing and drives tumor formation. In wounds of mice lacking HMGB1 selectively in keratinocytes, a marked reduction in neutrophil extracellular trap (NET) formation is observed. Pharmacological targeting of HMGB1 or NETs prevents skin tumorigenesis and accelerates wound regeneration. HMGB1-dependent NET formation and skin tumorigenesis is orchestrated by tumor necrosis factor (TNF) and requires RIPK1 kinase activity. NETs are present in the microenvironment of keratinocyte-derived tumors in mice and lesional and tumor skin of patients suffering from recessive dystrophic epidermolysis bullosa, a disease in which skin blistering predisposes to tumorigenesis. We conclude that tumorigenicity of the wound microenvironment depends on epithelial-derived HMGB1 regulating NET formation, thereby establishing a mechanism linking reparative inflammation to tumor initiation. : Inflammation mediates tissue repair but can be hijacked to promote tumorigenesis. Hoste et al. demonstrate that HMGB1 delays regeneration and drives tumor formation in skin by recruitment and priming of neutrophils. These data indicate that therapies targeting HMGB1 or NET formation might be relevant in chronic and diabetic wound treatment. Keywords: tumor microenvironment, skin inflammation, innate immunity, neutrophil extracellular traps, HMGB1, TNF, wound healing, diabetes, epidermolysis bullosa